Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00736879

Public ClinicalTrials.gov record NCT00736879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn if BMS-512148 (Dapagliflozin) can help reduce the blood sugar levels in subjects with Type 2 Diabetes who are not well controlled on diet and exercise alone. The safety of this treatment will also be studied

Study identification

NCT ID
NCT00736879
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
497 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 77 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2008 (Actual)
Primary completion
Dec 29, 2009 (Actual)
Completion
Dec 29, 2009 (Actual)
Last update posted
Apr 20, 2017

2008 – 2009

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Dedicated Clinical Research Litchfield Park Arizona 85340 —
43rd Medical Associates, P.C. Phoenix Arizona 85051 —
Clinical Research Advantage, Inc. Tempe Arizona 85282 —
Valley Research Fresno California 93720 —
Marina Raikhel, Md, Faafp Lomita California 90717 —
Richard S. Cherlin, Md Los Gatos California 95032 —
Orange County Research Center Tustin California 92780 —
Family Physicians Of Greeley Greeley Colorado 80634 —
Coastal Connecticut Research, Llc New London Connecticut 06320 —
Central Florida Clinical Trials, Inc. Altamonte Springs Florida 32701 —
Westside Center For Clinical Research Jacksonville Florida 32205 —
Panhandle Family Care Associates Marianna Florida 32446 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Belzoni Clinical Research Belzoni Mississippi 39038 —
R-Research Hamilton New Jersey 08690 —
Internist Associates Of Central New York Syracuse New York 13210 —
Southgate Medical Group West Seneca New York 14224 —
Down East Medical Associates, Pa Morehead City North Carolina 28557 —
James J. Brown, Md Akron Ohio 44319 —
Integris Family Care South Oklahoma City Oklahoma 73170 —
Southeastern Research Associates, Inc. Taylors South Carolina 29687 —
Abbott Clinical Research Group, Inc San Antonio Texas 78224 —
Avastra Clinical Trials Midvale Utah 84047 —
Optimum Clinical Research, Inc. Salt Lake City Utah 84102 —
Capital Clinical Research Center Olympia Washington 98502 —
Stephen G. Danley, Do Spokane Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00736879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00736879 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →